# Lutz T. Weber

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/lutz-t-weber/

## Facts

| Field | Value |
| --- | --- |
| Citations | 7,432 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 45 |
| i10-index | 133 |
| Last Known Institution | University Hospital Cologne |
| OpenAlex ID | https://openalex.org/A5017241443 |
| ORCID iD | 0000-0003-4116-598X |
| Works | 362 |

## Researcher papers

- [Opportunities to Optimize Tacrolimus Therapy in Solid Organ Transplantation: Report of the European Consensus Conference](https://scholariq.org/papers/opportunities-to-optimize-tacrolimus-therapy-in-solid-organ-transplantation/)
- [The Pharmacokinetic-Pharmacodynamic Relationship for Total and Free Mycophenolic Acid in Pediatric Renal Transplant Recipients](https://scholariq.org/papers/the-pharmacokinetic-pharmacodynamic-relationship-for-total-and-free-mycophenolic/)
- [IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome](https://scholariq.org/papers/ipna-clinical-practice-recommendations-for-the-diagnosis-and-management-of-2/)
- [ARHGDIA mutations cause nephrotic syndrome via defective RHO GTPase signaling](https://scholariq.org/papers/arhgdia-mutations-cause-nephrotic-syndrome-via-defective-rho-gtpase-signaling/)
- [Mutations in Multiple PKD Genes May Explain Early and Severe Polycystic Kidney Disease](https://scholariq.org/papers/mutations-in-multiple-pkd-genes-may-explain-early-and-severe-polycystic-kidney/)
- [Pharmacokinetics of mycophenolic acid (MPA) and determinants of MPA free fraction in pediatric and adult renal transplant recipients. German Study group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Recipients.](https://scholariq.org/papers/pharmacokinetics-of-mycophenolic-acid-mpa-and-determinants-of-mpa-free-fraction/)
- [KANK deficiency leads to podocyte dysfunction and nephrotic syndrome](https://scholariq.org/papers/kank-deficiency-leads-to-podocyte-dysfunction-and-nephrotic-syndrome/)
- [Mycophenolate Mofetil versus Cyclosporin A in Children with Frequently Relapsing Nephrotic Syndrome](https://scholariq.org/papers/mycophenolate-mofetil-versus-cyclosporin-a-in-children-with-frequently-relapsing/)
- [A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport’s syndrome](https://scholariq.org/papers/a-multicenter-randomized-placebo-controlled-double-blind-phase-3-trial-with-open/)
- [Rapid Response to Cyclosporin A and Favorable Renal Outcome in Nongenetic Versus Genetic Steroid–Resistant Nephrotic Syndrome](https://scholariq.org/papers/rapid-response-to-cyclosporin-a-and-favorable-renal-outcome-in-nongenetic-versus/)
- [Repetitive administration of rituximab can achieve and maintain clinical remission in patients with MCD or FSGS](https://scholariq.org/papers/repetitive-administration-of-rituximab-can-achieve-and-maintain-clinical/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)
- [Pediatric Urology and Nephrology Studies](https://scholariq.org/topics/pediatric-urology-and-nephrology-studies/)
- [Biomedical Research and Pathophysiology](https://scholariq.org/topics/biomedical-research-and-pathophysiology/)
- [Complement system in diseases](https://scholariq.org/topics/complement-system-in-diseases/)

## Researcher university

- [University Hospital Cologne](https://scholariq.org/institutions/university-hospital-cologne/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.